欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号BE/V/0035/001
药品名称Butagran Equi 200 mg/g Oral Powder for Horses
活性成分
    • phenylbutazone 200.0 mg/ml
剂型Oral powder
上市许可持有人Dopharma Research B.V. Zalmweg 24 4941 VX Raamsdonksveer The Netherlands
参考成员国 - 产品名称Belgium (BE)
Butagran Equi 200 mg/g oral powder for horses
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Butagran Equi 200 mg/g Oral Powder for Horses
    • Germany (DE)
      Butagran Equi, oral powder for horses
    • Denmark (DK)
      Butagran Equi
    • Austria (AT)
    • Spain (ES)
    • Italy (IT)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      BUTAGRAN EQUI 200 mg/g, geriamieji milteliai arkliams
    • Estonia (EE)
      Butagran Equi
    • Bulgaria (BG)
    • Romania (RO)
许可日期2012/11/27
最近更新日期2018/10/04
药物ATC编码
    • QM01AA01 phenylbutazone
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase